Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.345 HKD | -4.17% | +4.55% | -44.35% |
04-12 | Clover Biopharmaceuticals, Ltd. announced that it has received $0.320713 million in funding | CI |
04-08 | Clover Biopharmaceuticals' RSV Vaccine Candidate Shows Promise in Early Trial | MT |
Business Summary
Number of employees: 387
Managers
Managers | Title | Age | Since |
---|---|---|---|
Joshua Liang
CEO | Chief Executive Officer | - | 20-12-24 |
Aileen Wang
DFI | Director of Finance/CFO | - | 21-02-28 |
Htay Htay Han
CTO | Chief Tech/Sci/R&D Officer | 56 | 21-02-02 |
Wang Xiaoyan
SEC | Corporate Secretary | - | 23-03-30 |
Lily Yang
HRO | Human Resources Officer | - | 21-04-30 |
Liong Ho Chua
PRN | Corporate Officer/Principal | 60 | 22-04-26 |
Xiao Bing Li
PRN | Corporate Officer/Principal | 56 | 20-07-26 |
Hing Ling Chau
SEC | Corporate Secretary | 49 | 21-12-21 |
Members of the board
Members of the board | Title | Age | Since |
---|---|---|---|
Jeffrey Farrow
BRD | Director/Board Member | 62 | 21-04-18 |
Xiao Dong Wang
BRD | Director/Board Member | 61 | 21-03-15 |
Xiao Bin Wu
BRD | Director/Board Member | 62 | 21-04-18 |
Donna Ambrosino
BRD | Director/Board Member | 72 | 22-06-16 |
Ralf Clemens
BRD | Director/Board Member | 71 | 22-06-16 |
Thomas Leggett
BRD | Director/Board Member | 47 | 21-04-18 |
Peng Liang
CHM | Chairman | 63 | 18-10-30 |
Joshua Liang
CEO | Chief Executive Officer | - | 20-12-24 |
Xiang Liao
BRD | Director/Board Member | 59 | 21-04-18 |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 1 | 1,296,995,429 | 634,387,467 ( 48.91 %) | 0 | 48.91 % |
Company contact information
Clover Biopharmaceuticals Ltd.
49F, Park Place 1598-1601 West Nanjing Road
200010, Shanghai
+
http://www.cloverbiopharma.comSector
Sales per region
Quarterly revenue - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
-44.35% | 59.65M | |
-2.31% | 103B | |
+0.56% | 95.28B | |
+0.49% | 22.15B | |
-17.37% | 21.02B | |
-8.98% | 18.15B | |
-41.01% | 16.73B | |
-14.85% | 16.05B | |
+3.21% | 13.68B | |
+33.54% | 12.17B |
- Stock Market
- Equities
- 2197 Stock
- Company Clover Biopharmaceuticals, Ltd.